NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLA
Source: www.businesswire.com
Takeda Pharmaceutical Company Limited announced that its shareholders approved resolutions related to the proposed acquisition of U.K. drugmaker Shire plc. The expected completion of the acquisition will be by January 8, 2019. This takeover would make Takeda one of the world’s top 10 drug makers. Reportedly nearly 90% of Takeda shareholders voted to approve the deal at an extraordinary general meeting held in Osaka, Western Japan. The Acquisition remains subject to approval by Shire shareholders and to the sanctioning of the Shire scheme of arrangement by the Jersey Court at a hearing expected to be held on January 3, 2019.
